Sign In  |  Register  |  About Corte Madera  |  Contact Us

Corte Madera, CA
September 01, 2020 10:27am
7-Day Forecast | Traffic

  • Search Hotels in Corte Madera

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mersana Therapeutics Inc (NQ: MRSN )

1.530 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 570,357
Open 1.560
Bid (Size) 1.510 (1)
Ask (Size) 1.540 (1)
Prev. Close 1.530
Today's Range 1.470 - 1.560
52wk Range 0.8014 - 9.620
Shares Outstanding 71,761,525
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Preview Of Mersana Therapeutics's Earnings
Via Benzinga
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant... 
Via PressReach

Performance

YTD
-73.30%
-73.30%
1 Month
+37.84%
+37.84%
3 Month
+24.39%
+24.39%
6 Month
-78.36%
-78.36%
1 Year
-76.46%
-76.46%

More News

Read More
How To Invest In The Healthcare Sector
Via Talk Markets
Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
Via Benzinga
Why Mersana Therapeutics Stock Is Plunging Today?
Via Benzinga
What 4 Analyst Ratings Have To Say About Mersana Therapeutics
Via Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
Via Benzinga
Dow Jumps 100 Points; US GDP Rises 2.4% In Q2
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Via Benzinga
Cancer Drug Trials Put On Hold After Patients Died
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday
Via Benzinga
Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results
Via Benzinga
Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Dow Surges Over 300 Points; Kroger Profit Beats Views
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
Via Benzinga
US Stocks Open Higher; Retail Sales Rise In May
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 CorteMadera.com & California Media Partners, LLC. All rights reserved.